Metabolic Syndrome and Psychiatric Illness: Interactions, Pathophysiology, Assessment & Treatment: Interactions, Pathophysiology, Assessment & Treatment
Mendelson, Scott D
In stock
Regular price
45.250 KD
inc. VAT
Couldn't load pickup availability
Table of contents
- Table of Contentsv
- ACKNOWLEDGMENTSxi
- FOREWORDxiii
- Chapter 1 Gerald Reaven and the Discovery of Syndrome X1
- References9
- Chapter 2 Factors that Contribute to Metabolic Syndrome11
- Genetics11
- Carbohydrates and the Glycemic Index12
- Fructose14
- Fiber14
- Fatty Acids and how they Differ15
- Saturated Fat16
- Omega-3 and Omega-616
- Trans Fats17
- Micronutrients18
- Salt20
- Exercise21
- Smoking and Drinking21
- Obesity22
- References23
- Chapter 3 The Pathophysiology of Metabolic Syndrome27
- Insulin27
- Insulin Resistance and Compensatory Hyperinsulinemia28
- The Rise of the Adipocyte29
- Leptin30
- Adipocytes, Insulin, and Metabolic Syndrome32
- Muscle33
- The Liver34
- The Liver, Fat, and Insulin Resistance35
- Non-alcoholic Fatty Liver Disease36
- Hormonal Interactions in the Liver37
- Peroxisome Proliferation Activating Receptors37
- Inflammation38
- Oxidative Stress39
- Lipotoxicity41
- Asymmetrical Dimethylarginine42
- Stress and Cortisol43
- References44
- Chapter 4 Metabolic Syndrome and Psychiatric Illness49
- Major Depression49
- Insulin Resistance and Major Depression50
- Stress51
- Inflammation53
- Obesity54
- The Liver, Metabolic Syndrome and Major Depression55
- Cholesterol and Suicide56
- Seasonal Affective Disorder57
- Bipolar Affective Disorder59
- Anxiety Disorders60
- Schizophrenia63
- Metabolic Syndrome, Schizophrenia, and the NMDA Receptor64
- Fibromyalgia65
- Polycystic Ovary Disease66
- References66
- Chapter 5 Psychiatric Medications and Metabolic Syndrome73
- Antidepressants73
- Mood Stabilizers75
- Atypical Antipsychotics76
- Atypical Antipsychotics and Weight Gain77
- Genetics and Atypical Antipsychotic-induced Weight Gain77
- Mechanisms of Atypical Antipsychotic-induced Weight Gain78
- Atypical Antipsychotics and Insulin Resistance79
- Effects of Atypical Antipsychotics on Serum Lipids80
- Atypical Antipsychotics and Diabetes81
- Hyperprolactinemia82
- Guidelines for Monitoring Patients on Atypical Antipsychotics83
- Add-on Treatments to Counter Weight Gain and Metabolic Syndrome84
- Difficult Choices Must be Made86
- References86
- Chapter 6 Depression, Metabolic Syndrome, and Heart Disease93
- Dysrhythmias94
- Heart Failure95
- Ischemic Heart Disease and Myocardial Infarction95
- Platelet Hyperactivity96
- Inflammation97
- Stress98
- Lipid Abnormalities99
- Does Treating Major Depression Reduce Cardiac Risk?100
- References101
- Chapter 7 Metabolic Syndrome, Insulin and Alzheimer’s Disease105
- The Stages of Alzheimer’s Disease106
- Plaques and Tangles107
- Insulin and Alzheimer’s Disease107
- Insulin-Degrading Enzyme and Amyloid109
- Insulin and Tangled Tau110
- Inflammation and Alzheimer’s Disease111
- References113
- Chapter 8 Metabolic Syndrome, Sleep, and Sex115
- Sleep Apnea115
- Hypoxia116
- Sleep Apnea, Stress, and Metabolic Syndrome117
- Smuggling, Snoring and the Velopharynx118
- Sleep, Mood and Glycogen Synthase Kinase-3 (GSK-3)119
- Sleep Apnea and Alzheimer’s Disease120
- Inadequate Sleep and Altered Sleep Schedules121
- Metabolic Syndrome and Sex122
- References125
- Chapter 9 Diets for Weight Loss and Metabolic Syndrome129
- Low-Fat, High-Carbohydrate Diets130
- A Few Words about Protein131
- Diet, Appetite, and Satiety132
- Thermic Effects of Food134
- The Atkins Diet134
- Other Low-Carbohydrate Diets136
- Gerald Reaven’s Syndrome X Diet136
- The Mediterranean Diet137
- The Bottom Line on Diet138
- References139
- Chapter 10 Nutritional Supplements and Metabolic Syndrome141
- Acetyl-Carnitine141
- Alpha-Lipoic Acid143
- Carnosine144
- Chocolate146
- Chromium147
- Coenzyme Q10149
- Curcumin150
- DHEA151
- Fish Oil (Omega-3 Fatty Acids, EPA, DHA)152
- Ginseng157
- Leucine159
- Niacin (Nicotinic Acid, Vitamin B3)162
- Resveratrol164
- S-adenosylmethionine (SAMe)166
- Silymarin171
- Vanadium172
- Vitamin D174
- References176
- Chapter 11 Conclusion: Metabolic Syndrome and what to do about it187
- The First Step188
- Diet188
- Exercise190
- Sleep190
- Stress Reduction191
- Bad Habits192
- Treat Co-morbid Illness192
- Remember Hippocrates192
- References193
- INDEX195
Book details
- Vendor Elsevier S & T
- SKU 9780123742407
- ISBN-13 9780080556529
- Author Mendelson, Scott D
- Category Medical
- Subject Endocrinology & Metabolism
Do you have questions about this book?
Metabolic syndrome is a set of risk factors that includes: abdominal obesity, a decreased ability to process glucose (insulin resistance), dyslipidemia (unhealthy lipid levels), and hypertension. Patients who have this syndrome have been shown to be at an increased risk of developing cardiovascular disease and/or type 2 diabetes. Metabolic syndrome is a common condition that goes by many names (dysmetabolic syndrome, syndrome X, insulin resistance syndrome, obesity syndrome, and Reaven's syndrome).
This is the first book to fully explain the relationships between psychiatric illness, Metabolic Syndrome, diet, sleep, exercise, medications, and lifestyle choices. Metabolic Syndrome is a major risk factor in Major Depression, Alzheimer's Disease, Sleep Disorders, Sexual Dysfunction, Fibromyalgia, and several other illnesses of psychiatric significance. Conversely, some psychiatric illnesses tend to predispose patients to Metabolic Syndrome. Of further interest is the fact that some of the medications used in the treatment of psychiatric illnesses have been found to cause or exacerbate Metabolic Syndrome.
The author here provides basic information about what genetic predispositions, medical conditions, and lifestyle choices make Metabolic Syndrome more likely to occur. Among the contributing factors that are discussed are genetics, habitual intake of high glycemic index carbohydrates, fructose, saturated fats, trans fatty acids, vitamins, micronutrients, obesity, smoking, and lack of exercise.
The author describes the actual mechanisms by which Metabolic Syndrome progresses and causes damage in the body, including the action of insulin and the pathophysiology of insulin resistance. Details are provided on what occurs in the liver, pancreas, muscle, fat cells, and immune system as Metabolic Syndrome progresses. New findings are presented on fat cells, including the fact that they are beginning to be considered as endocrine cells. There is a substantive discussion of leptin, which is one of the important adipocytokines. Also carbohydrate, 'bad fats', inflammation, oxidative damage, over-stimulation of the 'fight or flight' system, and high levels of the stress hormone cortisol can actually cause the manifestations of Metabolic Syndrome. These explanations set the stage for an explanation of the inter-relationships between Metabolic Syndrome, psychiatric illness, dementia and effects of not only diet and life choices, but also the effects of psychiatric medications.
Finally, there is an important and unique section on the relationship between Metabolic Syndrome and various psychiatric illnesses, and how they exacerbate each other. The significance of Metabolic Syndrome in Major Depression, Bipolar Affective Disorder, Schizophrenia, fibromyalgia and Polycystic Ovary Disease is vast and it is important to realise the effects of psychiatric medications on Metabolic Syndrome. The author discusses antidepressants, mood stabilizers and the new atypical antipsychotics. There are dramatic differences among medications in the way they affect Metabolic Syndrome and pharmaceutical companies will want to promote patient awareness with this book.
This is the first book to fully explain the relationships between psychiatric illness, Metabolic Syndrome, diet, sleep, exercise, medications, and lifestyle choices. Metabolic Syndrome is a major risk factor in Major Depression, Alzheimer's Disease, Sleep Disorders, Sexual Dysfunction, Fibromyalgia, and several other illnesses of psychiatric significance. Conversely, some psychiatric illnesses tend to predispose patients to Metabolic Syndrome. Of further interest is the fact that some of the medications used in the treatment of psychiatric illnesses have been found to cause or exacerbate Metabolic Syndrome.
The author here provides basic information about what genetic predispositions, medical conditions, and lifestyle choices make Metabolic Syndrome more likely to occur. Among the contributing factors that are discussed are genetics, habitual intake of high glycemic index carbohydrates, fructose, saturated fats, trans fatty acids, vitamins, micronutrients, obesity, smoking, and lack of exercise.
The author describes the actual mechanisms by which Metabolic Syndrome progresses and causes damage in the body, including the action of insulin and the pathophysiology of insulin resistance. Details are provided on what occurs in the liver, pancreas, muscle, fat cells, and immune system as Metabolic Syndrome progresses. New findings are presented on fat cells, including the fact that they are beginning to be considered as endocrine cells. There is a substantive discussion of leptin, which is one of the important adipocytokines. Also carbohydrate, 'bad fats', inflammation, oxidative damage, over-stimulation of the 'fight or flight' system, and high levels of the stress hormone cortisol can actually cause the manifestations of Metabolic Syndrome. These explanations set the stage for an explanation of the inter-relationships between Metabolic Syndrome, psychiatric illness, dementia and effects of not only diet and life choices, but also the effects of psychiatric medications.
Finally, there is an important and unique section on the relationship between Metabolic Syndrome and various psychiatric illnesses, and how they exacerbate each other. The significance of Metabolic Syndrome in Major Depression, Bipolar Affective Disorder, Schizophrenia, fibromyalgia and Polycystic Ovary Disease is vast and it is important to realise the effects of psychiatric medications on Metabolic Syndrome. The author discusses antidepressants, mood stabilizers and the new atypical antipsychotics. There are dramatic differences among medications in the way they affect Metabolic Syndrome and pharmaceutical companies will want to promote patient awareness with this book.
Instant delivery by email
Your access email arrives within minutes of checkout, with a sign-in link for each book — no shipping, no waiting.
Read on any device
Books open in VitalSource Bookshelf on your phone, tablet, or computer, online or offline. Your library is always available at aafaq.vitalsource.com — just log in with the email you used at checkout.
Lost the email?
Resend it to yourself in seconds from My eBook orders, or email cs@aafaqeducation.com and we'll help.